RAY B — RaySearch Laboratories AB (publ) Balance Sheet
0.000.00%
- SEK8.50bn
- SEK8.55bn
- SEK1.19bn
Annual balance sheet for RaySearch Laboratories AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 169 | 103 | 160 | 344 | 463 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 362 | 384 | 398 | 414 | 511 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 577 | 516 | 628 | 802 | 985 |
Net Property, Plant And Equipment | 187 | 667 | 649 | 590 | 527 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,285 | 1,745 | 1,876 | 1,953 | 2,091 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 428 | 517 | 614 | 675 | 704 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 591 | 1,116 | 1,219 | 1,217 | 1,214 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 694 | 628 | 657 | 735 | 877 |
Total Liabilities & Shareholders' Equity | 1,285 | 1,745 | 1,876 | 1,953 | 2,091 |
Total Common Shares Outstanding |